These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27354937)

  • 1. Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease.
    Mulder N; Nembaware V; Adekile A; Anie KA; Inusa B; Brown B; Campbell A; Chinenere F; Chunda-Liyoka C; Derebail VK; Geard A; Ghedira K; Hamilton CM; Hanchard NA; Haendel M; Huggins W; Ibrahim M; Jupp S; Kamga KK; Knight-Madden J; Lopez-Sall P; Mbiyavanga M; Munube D; Nirenberg D; Nnodu O; Ofori-Acquah SF; Ohene-Frempong K; Opap KB; Panji S; Park M; Pule G; Royal C; Sangeda R; Tayo B; Treadwell M; Tshilolo L; Wonkam A
    Appl Transl Genom; 2016 Jun; 9():23-9. PubMed ID: 27354937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sickle Cell Disease Ontology: recent development and expansion of the universal sickle cell knowledge representation.
    Mazandu GK; Hotchkiss J; Nembaware V; Wonkam A; Mulder N
    Database (Oxford); 2022 Apr; 2022():. PubMed ID: 35363306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sickle Cell Disease Ontology: enabling universal sickle cell-based knowledge representation.
    Sickle Cell Disease Ontology Working Group
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31769834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease: current activities, public health implications, and future directions.
    Creary M; Williamson D; Kulkarni R
    J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa.
    Hsu L; Nnodu OE; Brown BJ; Tluway F; King S; Dogara LG; Patil C; Shevkoplyas SS; Lettre G; Cooper RS; Gordeuk VR; Tayo BO
    J Trop Dis Public Health; 2018; 6(2):260. PubMed ID: 30505949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica.
    Paintsil V; Ally M; Isa H; Anie KA; Mgaya J; Nkanyemka M; Nembaware V; Oppong-Mensah YG; Ndobho F; Chirande L; Makubi A; Nnodu O; Wonkam A; Makani J; Ohene-Frempong K
    Front Genet; 2022; 13():1052179. PubMed ID: 36712852
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
    Bello-Manga H; DeBaun MR; Kassim AA
    Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilising the 'Getting to Outcomes
    Inusa BPD; Anie KA; Lamont A; Dogara LG; Ojo B; Ijei I; Atoyebi W; Gwani L; Gani E; Hsu L
    Int J Neonatal Screen; 2018 Dec; 4(4):33. PubMed ID: 33072954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
    Diallo DA; Guindo A
    Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.
    Odame I; Kulkarni R; Ohene-Frempong K
    Am J Prev Med; 2011 Dec; 41(6 Suppl 4):S417-21. PubMed ID: 22099367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine signaling in normal and sickle erythrocytes and beyond.
    Zhang Y; Xia Y
    Microbes Infect; 2012 Aug; 14(10):863-73. PubMed ID: 22634345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging point-of-care technologies for sickle cell disease diagnostics.
    Ilyas S; Simonson AE; Asghar W
    Clin Chim Acta; 2020 Feb; 501():85-91. PubMed ID: 31678569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D; McGann PT
    Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of infant and maternal sickle cell disease on birth outcome and neonatal course.
    Brown AK; Sleeper LA; Pegelow CH; Miller ST; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1156-62. PubMed ID: 7921116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies.
    McGann PT; Hoppe C
    Blood Cells Mol Dis; 2017 Sep; 67():104-113. PubMed ID: 28844459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of establishing a network of community health workers to support care of people with sickle cell disease in Kumasi, Ghana.
    Buser JM; Bakari A; Moyer CA
    J Community Genet; 2021 Jan; 12(1):155-161. PubMed ID: 33403556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.